Literature DB >> 28689025

Venom-derived peptide inhibitors of voltage-gated potassium channels.

Raymond S Norton1, K George Chandy2.   

Abstract

Voltage-gated potassium channels play a key role in human physiology and pathology. Reflecting their importance, numerous channelopathies have been characterised that arise from mutations in these channels or from autoimmune attack on the channels. Voltage-gated potassium channels are also the target of a broad range of peptide toxins from venomous organisms, including sea anemones, scorpions, spiders, snakes and cone snails; many of these peptides bind to the channels with high potency and selectivity. In this review we describe the various classes of peptide toxins that block these channels and illustrate the broad range of three-dimensional structures that support channel blockade. The therapeutic opportunities afforded by these peptides are also highlighted. This article is part of the Special Issue entitled 'Venom-derived Peptides as Pharmacological Tools.'
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cone snail; Peptide; Potassium channel; Scorpion; Sea anemone; Snake; Spider; Therapeutic

Mesh:

Substances:

Year:  2017        PMID: 28689025     DOI: 10.1016/j.neuropharm.2017.07.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  KCa1.1 channels as therapeutic targets for rheumatoid arthritis.

Authors:  Christine Beeton
Journal:  Expert Opin Ther Targets       Date:  2017-10-31       Impact factor: 6.902

Review 2.  The Kv1.3 K+ channel in the immune system and its "precision pharmacology" using peptide toxins.

Authors:  Zoltan Varga; Gabor Tajti; Gyorgy Panyi
Journal:  Biol Futur       Date:  2021-02-06

3.  Anti-inflammatory effects of FS48, the first potassium channel inhibitor from the salivary glands of the flea Xenopsylla cheopis.

Authors:  Zhenhui Deng; Qingye Zeng; Jie Tang; Bei Zhang; Jinwei Chai; John F Andersen; Xin Chen; Xueqing Xu
Journal:  J Biol Chem       Date:  2021-04-14       Impact factor: 5.157

Review 4.  Sea Anemones: Quiet Achievers in the Field of Peptide Toxins.

Authors:  Peter J Prentis; Ana Pavasovic; Raymond S Norton
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

Review 5.  Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

Authors:  Mohammad H Baig; Khurshid Ahmad; Gulam Rabbani; Inho Choi
Journal:  Front Aging Neurosci       Date:  2018-02-07       Impact factor: 5.750

Review 6.  Snake Venom Peptides: Tools of Biodiscovery.

Authors:  Aisha Munawar; Syed Abid Ali; Ahmed Akrem; Christian Betzel
Journal:  Toxins (Basel)       Date:  2018-11-14       Impact factor: 4.546

7.  Kalium 2.0, a comprehensive database of polypeptide ligands of potassium channels.

Authors:  Valentin M Tabakmakher; Nikolay A Krylov; Alexey I Kuzmenkov; Roman G Efremov; Alexander A Vassilevski
Journal:  Sci Data       Date:  2019-05-27       Impact factor: 6.444

8.  Assigning biological function using hidden signatures in cystine-stabilized peptide sequences.

Authors:  S M Ashiqul Islam; Christopher Michel Kearney; Erich J Baker
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

9.  Tuning Scorpion Toxin Selectivity: Switching From KV1.1 to KV1.3.

Authors:  Andrei M Gigolaev; Alexey I Kuzmenkov; Steve Peigneur; Valentin M Tabakmakher; Ernesto L Pinheiro-Junior; Anton O Chugunov; Roman G Efremov; Jan Tytgat; Alexander A Vassilevski
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

10.  Magnificamide, a β-Defensin-Like Peptide from the Mucus of the Sea Anemone Heteractis magnifica, Is a Strong Inhibitor of Mammalian α-Amylases.

Authors:  Oksana Sintsova; Irina Gladkikh; Aleksandr Kalinovskii; Elena Zelepuga; Margarita Monastyrnaya; Natalia Kim; Lyudmila Shevchenko; Steve Peigneur; Jan Tytgat; Emma Kozlovskaya; Elena Leychenko
Journal:  Mar Drugs       Date:  2019-09-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.